Hepatitis B Core IgM antibody (anti-HBcIgM) among hepatitis B Surface antigen (HBsAg) negative blood donors in Nigeria

<p>Abstract</p> <p>Background</p> <p>Transfusion associated Hepatitis B virus (TAHBV) continues to be a major problem despite mandatory screening for Hepatitis B surface Antigen (HBsAg). Presence of HBsAg is the common method for detecting hepatitis B infection. Unfortu...

Full description

Bibliographic Details
Main Authors: Japhet Margaret, Adesina Olufisayo, Donbraye Emmanuel, Adewumi Moses
Format: Article
Language:English
Published: BMC 2011-11-01
Series:Virology Journal
Subjects:
Online Access:http://www.virologyj.com/content/8/1/513
_version_ 1818380298237247488
author Japhet Margaret
Adesina Olufisayo
Donbraye Emmanuel
Adewumi Moses
author_facet Japhet Margaret
Adesina Olufisayo
Donbraye Emmanuel
Adewumi Moses
author_sort Japhet Margaret
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Transfusion associated Hepatitis B virus (TAHBV) continues to be a major problem despite mandatory screening for Hepatitis B surface Antigen (HBsAg). Presence of HBsAg is the common method for detecting hepatitis B infection. Unfortunately, this marker is not detected during the window period of the infection. Nigeria being a developing country cannot afford DNA testing of all collected units of blood which serve as the only possibility of achieving zero risk of transfusion associated HBV. Five different serological makers of hepatitis B virus (HBV) infection were therefore assessed to evaluate the reliability of using HBsAg marker alone in diagnosis of HBV infection among blood donors and to detect the serological evidence of the infection at the window period. This will preclude the possibility of transmitting hepatitis B through transfusion of Hepatitis B surface antigen (HBsAg) negative blood in Nigeria.</p> <p>Methods</p> <p>Between July and August 2009, 92 blood donors were enrolled for the study. The prevalence of 5 different markers of Hepatitis B virus infection was detected using Enzyme Linked Immunosorbent Assay (ELISA). Demographic factors were assessed during the study.</p> <p>Results</p> <p>HBsAg and its antibody (anti-HBs) was detected in 18 (19.6%) and 14(15.2%) of the 92 blood donors respectively. Anti-HBc IgM was found in 12(13.0%) of the 92 blood donors while Hepatitis B envelope antigen (HBeAg) and its antibody (anti-HBe) were detected in 4(8.9%) and 12(26.7%) respectively from 45 donors sampled. HBeAg is a marker of high infectivity and appears after HBsAg. At least one serological marker was detected in 30(32.6%) of the blood donors. Five (5.4%) of the 92 donors had anti-HBc IgM as the only serological evidence of hepatitis B virus infection.</p> <p>Conclusions</p> <p>The result of this study shows that five donors have anti-HBcIgM as the only serological evidence of HBV infection. Inclusion of anti-HBcIgM in routine screening of blood donors in Nigeria should be encouraged. This is the first study to assess anti-HBcIgM in the country.</p>
first_indexed 2024-12-14T02:16:27Z
format Article
id doaj.art-d8e1752ae73c49d9a9c15859bee2e7e1
institution Directory Open Access Journal
issn 1743-422X
language English
last_indexed 2024-12-14T02:16:27Z
publishDate 2011-11-01
publisher BMC
record_format Article
series Virology Journal
spelling doaj.art-d8e1752ae73c49d9a9c15859bee2e7e12022-12-21T23:20:38ZengBMCVirology Journal1743-422X2011-11-018151310.1186/1743-422X-8-513Hepatitis B Core IgM antibody (anti-HBcIgM) among hepatitis B Surface antigen (HBsAg) negative blood donors in NigeriaJaphet MargaretAdesina OlufisayoDonbraye EmmanuelAdewumi Moses<p>Abstract</p> <p>Background</p> <p>Transfusion associated Hepatitis B virus (TAHBV) continues to be a major problem despite mandatory screening for Hepatitis B surface Antigen (HBsAg). Presence of HBsAg is the common method for detecting hepatitis B infection. Unfortunately, this marker is not detected during the window period of the infection. Nigeria being a developing country cannot afford DNA testing of all collected units of blood which serve as the only possibility of achieving zero risk of transfusion associated HBV. Five different serological makers of hepatitis B virus (HBV) infection were therefore assessed to evaluate the reliability of using HBsAg marker alone in diagnosis of HBV infection among blood donors and to detect the serological evidence of the infection at the window period. This will preclude the possibility of transmitting hepatitis B through transfusion of Hepatitis B surface antigen (HBsAg) negative blood in Nigeria.</p> <p>Methods</p> <p>Between July and August 2009, 92 blood donors were enrolled for the study. The prevalence of 5 different markers of Hepatitis B virus infection was detected using Enzyme Linked Immunosorbent Assay (ELISA). Demographic factors were assessed during the study.</p> <p>Results</p> <p>HBsAg and its antibody (anti-HBs) was detected in 18 (19.6%) and 14(15.2%) of the 92 blood donors respectively. Anti-HBc IgM was found in 12(13.0%) of the 92 blood donors while Hepatitis B envelope antigen (HBeAg) and its antibody (anti-HBe) were detected in 4(8.9%) and 12(26.7%) respectively from 45 donors sampled. HBeAg is a marker of high infectivity and appears after HBsAg. At least one serological marker was detected in 30(32.6%) of the blood donors. Five (5.4%) of the 92 donors had anti-HBc IgM as the only serological evidence of hepatitis B virus infection.</p> <p>Conclusions</p> <p>The result of this study shows that five donors have anti-HBcIgM as the only serological evidence of HBV infection. Inclusion of anti-HBcIgM in routine screening of blood donors in Nigeria should be encouraged. This is the first study to assess anti-HBcIgM in the country.</p>http://www.virologyj.com/content/8/1/513Hepatitis BTransfusionSerological markersELISABlood donors
spellingShingle Japhet Margaret
Adesina Olufisayo
Donbraye Emmanuel
Adewumi Moses
Hepatitis B Core IgM antibody (anti-HBcIgM) among hepatitis B Surface antigen (HBsAg) negative blood donors in Nigeria
Virology Journal
Hepatitis B
Transfusion
Serological markers
ELISA
Blood donors
title Hepatitis B Core IgM antibody (anti-HBcIgM) among hepatitis B Surface antigen (HBsAg) negative blood donors in Nigeria
title_full Hepatitis B Core IgM antibody (anti-HBcIgM) among hepatitis B Surface antigen (HBsAg) negative blood donors in Nigeria
title_fullStr Hepatitis B Core IgM antibody (anti-HBcIgM) among hepatitis B Surface antigen (HBsAg) negative blood donors in Nigeria
title_full_unstemmed Hepatitis B Core IgM antibody (anti-HBcIgM) among hepatitis B Surface antigen (HBsAg) negative blood donors in Nigeria
title_short Hepatitis B Core IgM antibody (anti-HBcIgM) among hepatitis B Surface antigen (HBsAg) negative blood donors in Nigeria
title_sort hepatitis b core igm antibody anti hbcigm among hepatitis b surface antigen hbsag negative blood donors in nigeria
topic Hepatitis B
Transfusion
Serological markers
ELISA
Blood donors
url http://www.virologyj.com/content/8/1/513
work_keys_str_mv AT japhetmargaret hepatitisbcoreigmantibodyantihbcigmamonghepatitisbsurfaceantigenhbsagnegativeblooddonorsinnigeria
AT adesinaolufisayo hepatitisbcoreigmantibodyantihbcigmamonghepatitisbsurfaceantigenhbsagnegativeblooddonorsinnigeria
AT donbrayeemmanuel hepatitisbcoreigmantibodyantihbcigmamonghepatitisbsurfaceantigenhbsagnegativeblooddonorsinnigeria
AT adewumimoses hepatitisbcoreigmantibodyantihbcigmamonghepatitisbsurfaceantigenhbsagnegativeblooddonorsinnigeria